mRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma.
- Author:
Zhong-sheng ZHAO
1
;
Guo-qing RU
;
Jie MA
Author Information
- Publication Type:Journal Article
- MeSH: Adenocarcinoma, Papillary; blood supply; metabolism; secondary; Adult; Aged; Carcinoma, Ductal; blood supply; metabolism; secondary; Carcinoma, Signet Ring Cell; blood supply; metabolism; secondary; Disease Progression; Female; Hepatocyte Growth Factor; biosynthesis; genetics; Humans; Insulin-Like Growth Factor II; biosynthesis; genetics; Liver Neoplasms; blood supply; metabolism; secondary; Lymphatic Metastasis; Male; Microcirculation; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Peritoneal Neoplasms; blood supply; metabolism; secondary; Prognosis; RNA, Messenger; biosynthesis; genetics; Stomach Neoplasms; blood supply; metabolism; pathology; Survival Rate
- From: Chinese Journal of Oncology 2004;26(11):673-677
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate whether correlation exists between mRNA expression of IGF-II and hepatocyte growth factor (HGF) and tumor progression and prognosis in gastric cancer.
METHODSIn situ hybridization technique was used to examine mRNA expression of IGF-II and HGF, and immunohistochemical technique was used to examine protein expression of CD34 in 105 specimens of gastric carcinoma.
RESULTSIn situ hybridization revealed that the positive rates of IGF-II mRNA and HGFmRNA were 49.5% and 57.1%, respectively. In stage T3-T4 cases, positive mRNA expression rates of IGF-II and HGF, the frequencies of vessel invasion, lymph node metastasis and distant metastasis were significantly higher than those in stage T1-T2 cases. The mean microvascular density (MVD) in stage T3-T4 tumors, vessel invasion, lymph node metastasis and distant metastasis were significantly more frequent than those in stage T1-T2 tumors. The mean MVD in tumors with positive IGF-II and HGF expressions was significantly higher than that in tumors without IGF-II and HGF expression. There were positive correlations between MVD and expression of IGF-II and HGF. The mean survival time and 5-year survival rate in cases with positive IGF-II and HGF expression and MVD value > or = 39.5 were significantly shorter those that in cases with negative IGF-II and HGF expression and MVD value < 39.5.
CONCLUSIONIGF-II and HGF promote angiogenesis in gastric cancer, and take part in tumor invasion and metastasis. They can be used as prognostic markers of gastric cancer in clinical practice.
